Neuhu+

Login

4D Pharma hopes to expand drug success to other areas - Duncan Peyton, CEO, 4D Pharma 00:00:00

4D Pharma hopes to expand drug success to other areas

Recent Videos

Contango Ore and Dolly Varden Silver Announce Merger to Create North American Precious Metals Powerhouse|Rick Van Nieuwenhuyse,CEO,Contango Ore

Turning Energy Infrastructure Into a Critical Mineral Engine|Bill McClain,Head of Investor Relations,LibertyStream Infrastucture Partners Inc

Cerrado Gold Eyes Massive Growth: Projecting $488 Million in Free Cash Flow by 2030|Mark Brennan,CEO,Cerrado Gold

Dryden Gold Accelerates Growth with $7.8M Financing and Major 2026 Drill Program in Ontario’s Prolific Gold Belt|Trey Wasser,CEO,Dryden Gold Corp

Sparton Resources CEO Lee Barker Targets 2025–26 Drilling at Oaks Gold Project Near Alamos Mine|Lee Barker,CEO,Sparton Resources

Talisker Resources Delivers First Gold Sales and Outlines 5-Year Path to 200,000+ Ounces Annual Production|Terry Harbort,CEO,Talisker Resources Ltd

Nuvos Therapeutics: Advancing Oxygen Nanobubble Therapy with Breakthrough Phase 2B Programs in Oncology, Stroke, and Respiratory Distress|Evan Unger,MD,NuvOx Therapeutics

Phenom Resources Advances Nevada Gold Portfolio with Active Drilling, Strategic Financing, and Multiple Upcoming Catalysts|Paul Cowley,CEO,Phenom Resources

Benton Resources Unlocks World-Class Copper-Gold Potential in Newfoundland with District-Scale Exploration Success|STEPHEN STARES,CEO,Benton Resources

Positioned at the Heart of Global Supply Chain Shift with UK, US, Uganda, and Brazil Projects Driving Ex-China Growth|Tim Harrison,Managing Director, Ionic Rare Earths Limited

Dakota Gold Unveils $2.1B Gold Project with Robust Economics, Long Mine Life, and Strategic U.S. Advantage|Robert Quartermain,CEO,Dakota Gold Corp

Terrain Minerals Targets Multi-Staged Gold & Gallium Growth with Smokebush Drilling, WA Gov-Funded Metallurgy, and New Copper-Gold Expansion|Justin Virgin,Executive Director

How LRT Capital's Lucas Krupinski Combines Economic Moats and Quant Discipline for Long-Term Outperformance|Mr. Tomicki,CEO,LRT Capital

AlphaBot Revolutionizes Alternative Investment Research with 10x Efficiency and Seamless Multi-Asset Integration at a Fraction of the Cost|Dmitri Alexeev,CIO,Man Group

Harcourt’s Strategy-Focused Fund of Hedge Funds Outperforms with Precision Manager Selection and Unmatched Fee Efficiency|Ilario Scasascia,ED,Vontobel Asset Management AG

Defying Convention with a Systematic Market Timing Strategy That Thrives in Volatility|Heeten H. Doshi,Founder,Doshi Capital